Blog
RSS FeedPosted by Michael Wonder on 09 Jan 2020
PHARMAC epilepsy drug process questions
10 January 2020 - There are many unanswered questions about PHARMAC's decision to fund only one brand of the epilepsy ...
Posted by Michael Wonder on 05 Jan 2020
'The public deserves to know why' - National intensifies calls for inquiry into PHARMAC after fifth death linked to epilepsy drug Logem
2 January 2020 - The National Party has intensified its call for a ministerial inquiry into PHARMAC's decision to switch ...
Posted by Michael Wonder on 05 Jan 2020
Dunedin couple towing coffin to Parliament in bid to double PHARMAC budget
3 January 2020 - A Dunedin couple is towing a coffin behind a tandem bike to Parliament in a call ...
Posted by Michael Wonder on 03 Jan 2020
PHARMAC - 2019 in review
2 January 2019 - Second lowest annual number of real world new medicines listed in New Zealand Pharmaceutical Schedule over ...
Posted by Michael Wonder on 02 Jan 2020
New Zealand Pharmaceutical Schedule - 1 January 2020 update
2 January 2020 - The January 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 19 Dec 2019
Request for information on lamotrigine brand change
9 December 2019 - The request, dated 15 November 2019, asked for all and any advice or information or guidance that ...
Posted by Michael Wonder on 18 Dec 2019
Proposal to fund mepolizumab for the treatment of severe refractory eosinophilic asthma
18 December 2019 - PHARMAC is seeking feedback on a proposal to fund mepolizumab (Nucala), a new treatment for severe ...
Posted by Michael Wonder on 17 Dec 2019
Comparison of PHARMAC with UK agency was misleading
17 December 2019 - The Broadcasting Standards Authority has upheld part of a complaint that an interview on Radio New ...
Posted by Michael Wonder on 17 Dec 2019
PHARMAC brand switch: man driving through Waterview Tunnel blacked out
18 December 2019 - An Auckland man had a seizure and blacked out as he drove through Auckland's Waterview Tunnel after ...
Posted by Michael Wonder on 17 Dec 2019
Calls for answers about PHARMAC delay after epilepsy deaths
17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for ...
Posted by Michael Wonder on 17 Dec 2019
Lamotrigine NPPA change
17 December 2019 - The request seeks all ‘communications’ between members of the PHARMAC senior leadership team, and in anticipation ...
Posted by Michael Wonder on 17 Dec 2019
Spinraza funding application reviewed by the Rare Disorders Subcommittee
17 December 2019 - PHARMAC has published the Rare Disorders Subcommittee meeting records which recommends Spinraza (nusinersen), a medication for ...
Posted by Michael Wonder on 16 Dec 2019
PHARMAC knew of epilepsy deaths for weeks but stayed silent
17 December 2019 - PHARMAC knew for more than two weeks that three deaths had been linked to its epilepsy ...
Posted by Michael Wonder on 16 Dec 2019
Flawed forecasting? Why New Zealand ran out of MMR vaccine
16 December 2019 - PHARMAC's forecast for how many doses of MMR vaccine would be needed for 2019 was around ...
Posted by Michael Wonder on 16 Dec 2019
Proposal to widen funded access to lenalidomide for multiple myeloma
16 December 2019 - PHARMAC is seeking feedback on a proposal to widened funded access to lenalidomide (Revlimid) to include ...